Inicio › Cáncer de próstata › Oregón › Portland
Ensayos clínicos de Cáncer de próstata en Portland, OR
33 estudios para Cáncer de próstata buscan participantes en centros de Portland y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
ReclutandoFase 2
- VA Portland Health Care System, Portland, OR, Portland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- Oregon Health & Science University (OHSU), Portland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
ReclutandoFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · A 12 mi de distancia
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
ReclutandoFase 4
- Oregon Health & Science University, Portland
Precision-Based Genomics in Prostate Cancer
ReclutandoEstudio observacional
- Oregon Health Sciences University, Portland
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
ReclutandoFase 1
- Oregon Health And Science University, Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
ReclutandoFase 1
- Providence Portland Medical Center, Portland
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
ReclutandoFase 2
- VA Portland Health Care System, Portland, OR, Portland
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
ReclutandoFase 2
- VA Portland Health Care System, Portland, OR, Portland
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ReclutandoFase 3
- VA Portland Health Care System ( Site 0038), Portland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ReclutandoFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Kaiser Permanente Northwest, Portland
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Reclutando
- Oregon Health & Science University, Portland
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
ReclutandoFase 2
- Oregon Health & Science University, Portland
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
ReclutandoFase 1/2
- Research Site, Portland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
ReclutandoFase 3
- Research Site, Portland
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutandoFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- y 1 más
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Oregon Health and Science University, Portland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- y 1 más
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
ReclutandoFase 1/2
- Oregon Health & Science University, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
ReclutandoFase 2
- VA Portland Health Care System, Portland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
ReclutandoEstudio observacional
- Oregon Health & Science University Hospital, Portland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- OHSU Knight Cancer Institute, Portland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 1
- Research Site, Portland
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Reclutando
- OHSU Knight Cancer Institute, Portland
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Reclutando
- OHSU Knight Cancer Institute, Portland
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
ReclutandoFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- y 1 más
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Oregon Health Sciences University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Portland
EMBRACE: Exercising Together
ReclutandoFase 2Se aceptan voluntarios sanos
- OHSU Knight Cancer Institute, Portland
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
ReclutandoFase 2
- VA Portland Healthcare System, Portland
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY103 estudios
- Houston, TX76 estudios
- Los Angeles, CA61 estudios
- Boston, MA59 estudios
- St. Louis, MO46 estudios
- Chicago, IL45 estudios
- San Francisco, CA45 estudios
- Philadelphia, PA44 estudios
- Baltimore, MD43 estudios
- Nashville, TN43 estudios
- Seattle, WA42 estudios
- Washington, DC38 estudios
Otros estudios en Portland
- Cáncer de pulmón de células no pequeñas46 estudios
- Cáncer (todos los tipos)34 estudios
- Cáncer de seno33 estudios
- Cáncer metastásico29 estudios
- Cáncer del colon y del recto28 estudios
- Cáncer de ovario27 estudios
- Cáncer de pulmón26 estudios
- Leucemia mielógena aguda25 estudios
- Cáncer de endometrio24 estudios
- Carcinoma de células escamosas de cabeza y cuello19 estudios
- Cáncer de páncreas19 estudios
- Fallo cardíaco17 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.